Photo from ESMO/LinkedIn
May 18, 2024, 03:08
AI in Breast Cancer management is revolutionising the field – ESMO
“The rapid integration of Artificial Intelligence in Breast Cancer management is revolutionising the field from detection to treatment. AI models are not medicines or devices, and many questions arise around validation, evidence, and acceptability. Suzette Delaloge emphasises the importance of professional oncology societies like ESMO in providing timely answers. It will also be necessary to ensure that its benefits are defined by solid evidence and supported by bespoke regulatory and reimbursement processes.
Read more in the ESMO Daily Reporter.”